X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
niacinamide - analogs & derivatives (6241) 6241
humans (5144) 5144
male (3170) 3170
animals (2778) 2778
female (2460) 2460
sorafenib (2089) 2089
niacinamide - pharmacology (1898) 1898
oncology (1856) 1856
phenylurea compounds (1817) 1817
middle aged (1746) 1746
antineoplastic agents - therapeutic use (1616) 1616
aged (1468) 1468
niacinamide - therapeutic use (1430) 1430
cancer (1300) 1300
liver neoplasms - drug therapy (1193) 1193
carcinoma, hepatocellular - drug therapy (1152) 1152
adult (1146) 1146
phenylurea compounds - therapeutic use (1130) 1130
niacinamide (1099) 1099
treatment outcome (1096) 1096
mice (1037) 1037
pyridines - therapeutic use (1005) 1005
benzenesulfonates - therapeutic use (970) 970
niacinamide - administration & dosage (954) 954
pharmacology & pharmacy (874) 874
cell line, tumor (869) 869
rats (856) 856
liver neoplasms - pathology (765) 765
hepatocellular carcinoma (754) 754
carcinoma, renal cell - drug therapy (735) 735
carcinoma, hepatocellular - pathology (724) 724
kidney neoplasms - drug therapy (722) 722
antineoplastic agents (706) 706
protein kinase inhibitors - therapeutic use (702) 702
antineoplastic agents - adverse effects (697) 697
antineoplastic agents - pharmacology (694) 694
phenylurea compounds - administration & dosage (680) 680
phenylurea compounds - pharmacology (671) 671
antimitotic agents (669) 669
care and treatment (626) 626
analysis (624) 624
niacinamide - adverse effects (591) 591
aged, 80 and over (571) 571
apoptosis (564) 564
nicorandil (555) 555
biochemistry & molecular biology (529) 529
pyridines - pharmacology (525) 525
dose-response relationship, drug (524) 524
phenylurea compounds - adverse effects (522) 522
liver cancer (510) 510
expression (505) 505
antineoplastic agents - administration & dosage (492) 492
pyridines - adverse effects (485) 485
research (478) 478
sunitinib (477) 477
therapy (475) 475
cell proliferation - drug effects (474) 474
benzenesulfonates - adverse effects (473) 473
chemotherapy (471) 471
survival (465) 465
antineoplastic combined chemotherapy protocols - therapeutic use (462) 462
apoptosis - drug effects (455) 455
disease-free survival (452) 452
pyridines - administration & dosage (452) 452
prognosis (446) 446
angiogenesis (442) 442
time factors (442) 442
protein kinase inhibitors - pharmacology (440) 440
retrospective studies (440) 440
benzenesulfonates - administration & dosage (430) 430
indoles - therapeutic use (423) 423
gastroenterology & hepatology (422) 422
niacinamide - metabolism (420) 420
benzenesulfonates - pharmacology (419) 419
hepatoma (413) 413
metastasis (408) 408
bevacizumab (397) 397
kidney neoplasms - pathology (397) 397
pyrroles - therapeutic use (393) 393
niacinamide - chemistry (387) 387
digestive system diseases (381) 381
neoplasms (375) 375
drug therapy (368) 368
protein kinase inhibitors - adverse effects (366) 366
tumors (366) 366
medicine & public health (365) 365
cell biology (363) 363
activation (356) 356
endothelial growth-factor (348) 348
nicotinamide (347) 347
signal transduction - drug effects (335) 335
in vitro techniques (331) 331
neoplasm staging (331) 331
carcinoma, hepatocellular - therapy (318) 318
liver neoplasms - therapy (313) 313
vasodilator agents - pharmacology (312) 312
efficacy (307) 307
liver neoplasms - mortality (295) 295
carcinoma, hepatocellular - mortality (293) 293
enzymes (293) 293
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7228) 7228
Japanese (204) 204
German (97) 97
French (89) 89
Chinese (79) 79
Russian (74) 74
Italian (60) 60
Spanish (20) 20
Hungarian (9) 9
Czech (7) 7
Ukrainian (6) 6
Dutch (5) 5
Portuguese (5) 5
Polish (4) 4
Turkish (3) 3
Korean (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Angewandte Chemie (International ed.), ISSN 1433-7851, 2018, Volume 57, Issue 42, pp. 13825 - 13828
...) catalyzes the stereoselective reduction of α,β-unsaturated hydrocarbons. Here, we report OYE-catalyzed asymmetric hydrogenation through light-driven regeneration of NADH and its analogues (mNADHs... 
alkene hydrogenation | asymmetric catalysis | NADH analogues | photobiocatalysis | carbon nanodot | OXIDATION | NICOTINAMIDE COFACTOR | PHOTOSENSITIZERS | COMPLEXES | CHEMISTRY, MULTIDISCIPLINARY | QUANTUM DOTS | VISIBLE-LIGHT | SOLAR-DRIVEN CATALYSIS | ENZYMES | CHEMISTRY | Niacinamide | Enzymes | Analysis | Olefins | Catalysis | Chemical synthesis | Hydrogenation | Adenine | Carbon | Substrates | Cofactors | NAD | Stereoselectivity | Regeneration | Organic chemistry | Reduction | NADH | Nicotinamide adenine dinucleotide | Nicotinamide | Unsaturated hydrocarbons
Journal Article
Angewandte Chemie, ISSN 1521-3757, 2018, Volume 130, Issue 42, pp. 14021 - 14024
...) catalyzes the stereoselective reduction of α,β-unsaturated hydrocarbons. Here, we report OYE-catalyzed asymmetric hydrogenation through light-driven regeneration of NADH and its analogues (mNADHs... 
alkene hydrogenation | asymmetric catalysis | NADH analogues | photobiocatalysis | carbon nanodot | NADH-Analoga | Kohlenstoff-Nanopunkte | Alkenhydrierung | Asymmetrische Katalyse | Photobiokatalyse | Niacinamide | Enzymes | Chemical synthesis | Hydrogenation | Analysis | Olefins | Adenine | Carbon | Substrates | Cofactors | NAD | Stereoselectivity | Regeneration | Organic chemistry | Reduction | NADH | Nicotinamide adenine dinucleotide | Nicotinamide | Unsaturated hydrocarbons
Journal Article
Journal Article
Bioorganic & medicinal chemistry, ISSN 0968-0896, 2018, Volume 26, Issue 7, pp. 1365 - 1373
Journal Article
Nuclear Medicine and Biology, ISSN 0969-8051, 2008, Volume 35, Issue 4, pp. 401 - 411
Abstract Introduction Radionuclide imaging can be a useful tool for the diagnosis of prostate cancer. Bombesin (BBN) is a molecule with high affinity for... 
Radiology | Bombesin analogs | technetium 99m ( 99mTc)-HYNIC-BBN | Prostate cancer | 99mTcN(PNP6)-Cys-BBN | technetium 99m | Tc)-HYNIC-BBN | TcN(PNP6)-Cys-BBN | VISUALIZATION | VITRO/IN VIVO | RECEPTOR | TC-99M-RADIOPHARMACEUTICALS | BIODISTRIBUTION | technetium 99m (Tc-99m)-HYNIC-BBN | prostate cancer | bombesin analogs | PEPTIDES | TC-99M | RADIOPHARMACEUTICALS | (TcN)-Tc-99m(PNP6)-Cys-BBN | IN-VIVO | BOMBINA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Niacinamide - analogs & derivatives | Nitrogen Compounds - pharmacokinetics | Phosphines - pharmacokinetics | Organotechnetium Compounds - chemical synthesis | Male | Metabolic Clearance Rate | Radiopharmaceuticals - chemical synthesis | Tissue Distribution | Hydrazines - chemistry | Prostate - pathology | Phosphines - chemistry | Bombesin - analogs & derivatives | Niacinamide - chemistry | Nitrogen Compounds - chemical synthesis | Drug Design | Niacinamide - pharmacokinetics | Prostatic Neoplasms - diagnostic imaging | Bombesin - chemistry | Drug Evaluation, Preclinical | Disease Models, Animal | Pancreas - diagnostic imaging | Organotechnetium Compounds - chemistry | Radiopharmaceuticals - pharmacokinetics | Drug Stability | Hydrazines - pharmacokinetics | Cysteine - chemistry | Isotope Labeling - methods | Animals | Organotechnetium Compounds - pharmacokinetics | Prostate - diagnostic imaging | Radionuclide Imaging | Cell Line, Tumor | Hydrophobic and Hydrophilic Interactions | Cysteine - pharmacokinetics | Mice | Bombesin - pharmacokinetics | Receptors, Bombesin - analysis | Bombesin | Oncology, Experimental | Gastrin | Technetium | Diagnostic imaging | Diagnosis | Research | Isotopes | Cancer
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 11, pp. 1687 - 1695
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2015, Volume 75, Issue 1, pp. 161 - 171
.... The use of structural analogues and derivatives of sorafenib has enabled the elucidation of critical targets and mechanism... 
Kinase selectivity profile | Medicine & Public Health | NCI-60 cell lines | Sorafenib analogue | Caspase-independent cell death | Oncology | Cancer Research | Pharmacology/Toxicology | Pharmacokinetics | Hepatoma cells | ADVANCED HEPATOCELLULAR-CARCINOMA | TARGET | APOPTOSIS-INDUCING FACTOR | MULTIKINASE INHIBITOR | RAF/MEK/ERK PATHWAY | CELL-DEATH | SOLUBLE EPOXIDE HYDROLASE | ONCOLOGY | PHARMACOLOGY & PHARMACY | GROWTH-FACTOR | EPOXYEICOSATRIENOIC ACIDS | Neoplasms - metabolism | Niacinamide - analogs & derivatives | Drugs, Investigational - pharmacology | Apoptosis - drug effects | raf Kinases - antagonists & inhibitors | Humans | Drugs, Investigational - pharmacokinetics | Half-Life | Biological Availability | Male | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - administration & dosage | Membrane Potential, Mitochondrial - drug effects | Neoplasm Proteins - metabolism | raf Kinases - metabolism | Drugs, Investigational - analysis | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Neoplasms - blood | Niacinamide - pharmacokinetics | Animals, Outbred Strains | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Phenylurea Compounds - pharmacokinetics | Drug Evaluation, Preclinical | Protein Kinase Inhibitors - pharmacokinetics | Cell Survival - drug effects | Niacinamide - blood | Administration, Oral | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Phenylurea Compounds - blood | Protein Kinase Inhibitors - blood | Neoplasms - drug therapy | Niacinamide - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Animals | Phenylurea Compounds - administration & dosage | Antineoplastic Agents - blood | Cell Line, Tumor | Drugs, Investigational - administration & dosage | Resting Phase, Cell Cycle - drug effects | Mice | Phenylurea Compounds - pharmacology | Protein Kinase Inhibitors - pharmacology | Niacinamide - pharmacology | Neoplasms - pathology | Antimitotic agents | Enzymes | Antineoplastic agents | Vascular endothelial growth factor | Drug approval | Analysis
Journal Article
Chembiochem : a European journal of chemical biology, ISSN 1439-7633, 2019, Volume 20, Issue 6, pp. 838 - 845
Journal Article
Science China Chemistry, ISSN 1674-7291, 3/2013, Volume 56, Issue 3, pp. 296 - 300
Three new nicotinamide adenine dinucleotide (NAD) analogs were synthesized, and their characteristics as cofactors for Escherichia coli malic enzyme (ME... 
oxidoreductases | Chemistry | bioorthogonal | chemical biology | Chemistry/Food Science, general | NAD analog | UNNATURAL NUCLEOTIDE SPECIFICITY | DINUCLEOTIDE | METHYLTRANSFERASE | RECEPTOR | CHEMISTRY, MULTIDISCIPLINARY | Oxidases | Niacinamide | Purines | Malic acid | Analysis | Green technology
Journal Article
Journal Article